20,000 dram banknote of 2024 issue put into circulation in Armenia

YEREVAN, January 27. /ARKA/. The Central Bank of Armenia reported about putting into circulation from January 27 this year a banknote with a nominal value of 20,000 drams of 2024 issue, which is a legal tender on the territory of the country and is subject to unconditional acceptance at its nominal value without time limitations.
On the reverse of the 2024 banknote a visible color protective element has been added: the figure expressing the nominal value in the lower left corner is printed with optically changing ink.
On the obverse of the banknote the year of issue has been changed to 2024, as well as the signature of the Armenian Minister of Finance.
The banknotes of 20,000 drams nominal value issued in 1999-2021 remain in circulation without restrictions and without changes in circulation conditions.

spot_img

POPULAR

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img